Relay Therapeutics, Inc. (RLAY) Financials

RLAY Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 844.0 million 92.0 million
2023-09-30 907.0 million 128.6 million
2023-06-30 962.0 million 151.9 million
2023-03-31 1.0 billion 154.1 million

RLAY Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -89.3 million 19.3 million
2023-09-30 -76.0 million 21.8 million
2023-06-30 -70.1 million 23.4 million
2023-03-31 -69.0 million 21.5 million

RLAY Net Income

No data available :(

RLAY Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 750.1 million - 53.5 million
2023-09-30 810.6 million - 54.6 million
2023-06-30 871.6 million - 55.7 million
2023-03-31 937.8 million - 56.7 million

RLAY Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 122.6 million
2023-09-30 122.2 million
2023-06-30 121.7 million
2023-03-31 121.3 million

RLAY Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 118000 77.5 million 16.8 million -
2023-09-30 590000 81.5 million 18.5 million -
2023-06-30 1.5 million 88.2 million 20.1 million -
2023-03-31 1.9 million 82.8 million 19.6 million -

RLAY Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 -1000 1.4 million
2023-09-30 25.2 million 1.4 million
2023-06-30 119000 1.3 million
2023-03-31 226000 1.2 million

RLAY

Price: $7.04

52 week price:
5.70
18.32

Earnings Per Share: -2.79 USD

P/E Ratio: -3.37

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 1.4 million

Market Capitalization: 934.5 million

Links: